Evidence map›Paper›PMID 40429644›Full record

ArticleInternational journal of molecular sciences2025

Rapid and Cost-Effective Diagnostic Blot Assays Based on the Use of Plant-Produced Recombinant Antigens: Lessons Learned from the SARS-CoV-2 RBD Antigen.

Chiara Miele, Dania Ramadan, Leonardo Lupacchini, Carla Marusic, Valeria D'Argenio, Maria Giovanna Valente, Antonella Spila, Gianluca Gessoni, Veronica Alfano, Patrizia Ferroni and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chiara MieleDepartment for the Promotion of Human Sciences and Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy.
Dania RamadanInterInstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele, 00166 Roma, Italy.
Leonardo LupacchiniLaboratory of Molecular and Cellular Neuroscience, IRCCS San Raffaele, 00166 Rome, Italy.ORCID 0000-0002-9172-7461
Carla MarusicDivision of Biotechnology, ENEA Casaccia Research Center, 00123 Roma, Italy.
Valeria D'ArgenioDepartment for the Promotion of Human Sciences and Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy.ORCID 0000-0001-9273-3698
Maria Giovanna ValenteInterInstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele, 00166 Roma, Italy.ORCID 0000-0003-0093-173X
Antonella SpilaInterInstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele, 00166 Roma, Italy.
Gianluca GessoniTransfusion Medicine Department of Venezia, Ospedale dell'Angelo-Mestre, 30173 Venezia, Italy.
Veronica AlfanoInterInstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele, 00166 Roma, Italy.
Patrizia FerroniDepartment for the Promotion of Human Sciences and Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy.ORCID 0000-0002-9877-8712
Marcello DoniniDivision of Biotechnology, ENEA Casaccia Research Center, 00123 Roma, Italy.ORCID 0000-0001-9183-0728
Fiorella GuadagniDepartment for the Promotion of Human Sciences and Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy.

Funding

Ministero della Salute Ricerca CorrenteMinistero dell'università e della ricerca 5X1000-2021
6 · The paper itself

Abstract

The ongoing demand for reliable, cost-effective, and scalable diagnostic solutions during the COVID-19 pandemic emphasized the need for innovative production platforms. In this study, we present a plant-based molecular farming (PMF) strategy for the production of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein fused with an Fc region (RBDw-Fc). The RBDw-Fc antigen was transiently expressed in the

Indexed as

Antigens, ViralCOVID-19COVID-19 Serological TestingSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ViralCost-Benefit AnalysisHumansMolecular FarmingNicotianaPlants, Genetically ModifiedRecombinant ProteinsSensitivity and SpecificityAntibodies, ViralAntigens, ViralRecombinant ProteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2diagnostic testsplant-based molecular farmingrecombinant antigensSARS-CoV-2

Identifiers

PMID40429644
PMCPMC12111317

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.